schizophrenia Flashcards

1
Q

defining schizophrenia

A
  • extremely complex mental disorders
  • disorder characterized by delusions, hallucinations, disturbances in thinking and communication and withdrawal from social activity
  • serious, treatable brain disorder which affects a persons ability to know what is reality and what is not
  • neurological illness
  • psychosis is one element of the illness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

epidemiology

A
  • halter states:
  • – lifetime prevalence of schizophrenia is 1% worldwide
  • – no difference related no
  • —- race
  • —- social status
  • —- culture
  • critical perspective: some compelling evidence that practitioner bias leads to systemic class/cultural bias against racial and ethnic minorities
  • more common in males and among persons growing up in urban areas
  • ages of onset; 18-25 is typical of males, with later onset of 25-35 more common in females and associated with better outcomes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

co-morbidity

A
  • substance use disorders
  • – nicotine, dependence
  • anxiety, depression, and suicide
  • physical illness
  • polydipsia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

social realities

A
  • family and caregiver stress
  • stigma and community isolation
  • homelessness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

psychological realities

A
  • difficulties in relating, decision making
  • affective blunting
  • decrease stress response and coping
  • self concept changes
  • self stigma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

tortured artist

A
  • creative people have a 90% higher chance of being diagnosed with schizophrenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

schizophrenia and the brain

A
  • dopamine pathways relevant to schizophrenia symptoms
  • – mesolimbic and mesocortical dopaminergic system are thought to play an important role in motivation, cognition; significant to stimuli
  • – overactivity of the mesolimbic pathway leads to positive symptoms
  • – mesocortical pathway dysfunction leads to negative and cognitive symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

too much or too little dopamine in different regions of the brain

A
  • mesolimbic:
  • – high levels of D2 dopamine receptors-impaired grasp of reality, emotional dysregulation
  • prefrontal cortex:
  • – reduction in dopamine can cause decline in neurocognitive fx, memory, attention and problem solving, social traits
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

role of glutamate

A
  • activates NMDA- forms connections between brain cells, significant in brain development, learning and memory
  • low NMDA thought to lead to schizophrenia later in life
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

theories of etiology

A

all lead to psychosis:

  • early causes; genetic, obstetric complications
  • vulnerability: neurocognitive impairments, social anxiety, isolation, odd ideas
  • abuse of DA drugs
  • social stress
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

etiology: stress and infection

A
  • the role of emotional and physical stress (infections) can trigger or worsen the symptoms when illness is already present
  • immune dysfunction
  • vulnerability stress theory
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

link between marijuana and psychosis

A
  • people who use marijuana regularly before the age of 16 are 6x more likely to develop a psychosis
  • exposure to THC during brain development is an environmental risk for schizophrenia
  • the effects of CBD on schizophrenia symptoms have been mixed. some studies have shown CBD antipsychotic potential while others found no therapeutic link
  • reality is by grad 12, 50% of students would have used cannabis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

phases of schizophrenia

A

nursing care depends on the phase

  • prodrome
  • acute
  • – onset or exacerbation of symptoms
  • stabilization
  • – symptoms diminishing
  • – movement toward previous level of functioning
  • maintenance
  • – at or near baseline functioning
  • health promotion
  • – improving health outcomes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

prodromal phase

A
  • may arise a year or so before first episode
  • most common symptoms based on retrospective studies
    • reduced concentration and attention
    • reduced drive and motivation
    • depression
    • sleep disturbances
    • anxiety
    • social withdrawal
    • suspiciousness
    • deterioration in role functioning
    • irritability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

positive symptoms

A
  • hallucinations (auditory, command, visual)
  • delusions (false, fixed belief)
  • racing thoughts
  • disorganized speech/behaviour
  • disturbed/bizarre behaviour
  • depersonalization (feeling of being detached from one’s body or mental processes)
  • derealization (a mental state where you feel detached from your surroundings)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

positive symptoms: altered speech

A
  • clang associations
  • associative looseness
  • word salad
  • neologisms (creating new words)
  • echolalia (meaningless repetition of words)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

positive symptoms: other disorders of thought or speech

A
  • flight of ideas
  • thought insertion
  • thought broadcasting
  • ideas of reference
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

positive symptoms: alterations in behaviour

A
  • motor retardation
  • motor agitation
  • catatonia
  • waxy flexibility (retain position moved into)
  • echopraxia (meaningless repetition of movement)
  • impaired impulse control
  • gesturing or posturing
  • boundary impairment
19
Q

negative symptoms

A
  • avolition: decreased motivation
  • affective flattening: decreased emotional expression (affect is blunt, flat, and inappropriate)
  • alogia: decreased fluency in thought and language
  • anhedonia: decreased willingness to engage in leisure/pleasure
20
Q

affective symptoms

A
  • assessment for depression is crucial
  • – may herald impending relapse
  • – increases substance use
  • – increases suicide risk
  • – each psychotic break further impairs functioning
21
Q

cognitive symptoms

A
  • difficulty with:
  • – attention
  • – memory
  • – information processing
  • – cognitive flexibility
  • – executive functions
22
Q

expected outcomes

A
  • 1/3 of pt with schizophrenia achieve lasting significant improvements (recover-remission)
  • 1/3 of pt improve somewhat but have relapses (mild to moderate symptoms)
  • 1/3 of pt remain disabled (chronic - 10% commit suicide)
23
Q

early detection

A
  • the sooner the symptoms are recognized and diagnosed, the sooner the person will benefit
  • once the symptoms and the fear that goes along with symptoms are addressed, recovery begins
  • important to R/O other diseases huntington’s disease, wilson’s disease, epilepsy, tumour, encephalitis, meningitis, MS and others
24
Q

schizophrenia prediction instrument (SPI-A)

A
  • at least two of nine of the following basic symptoms
  • -inability to divide attention
  • – thought interference
  • – thought blockage
  • – disturbance in receptive speech
  • – disturbance in expressive speech
  • – disturbance of abstract thinking (concretism)
  • – unstable ideas of reference (subject centrism)
  • – captivation of attention by details of the visual field
25
Q

first episode psychosis

A
  • psychosis: 3% of world pop
  • up to 1/3 of pt with schizophrenia have just one episode
  • important with each acute episode the prognosis worsens (toxic storm)
  • the experience is very frightening, confusing, distressing
  • psychosis is treatable
26
Q

types of psychosis

A
  • schizophrenia
  • schizophreniform disorder
  • bipolar
  • schizoaffective disorder
  • depression with psychotic features
  • drug induced psychosis
  • organic psychosis
  • delusional psychosis
27
Q

acute phase interventions

A
  • presence of frank psychosis (hallucinations, delusions, formal thought disorder)
  • nursing:
  • – therapeutic communication
  • – provide safety and support
  • – managing delusions and hallucinations
  • – prioritize care according to need, if not hallucinating (+ve) then focus on self withdrawal (-ve)
  • – self care deficit
  • – prevention of water intoxication (polydipsia)
  • – continual assessment, evaluate responsiveness to tx
28
Q

acute phase interventions: pharmacology

A
  • anti psychotics (neuroleptics): act as dopamine antagonists
  • antipsychotic medications
  • – first generation FGA -typical
  • – second generation SGA atypical
  • – third generation TGA atypical
29
Q

first generation typical antipsychotics

A

typical (traditional) anti psychotic (major tranquilizer) first gen (older)- thorazine, haloperidol, stelazine, loxipine, chlorpromazine, depot fluphenazine, flupentixol, Haldol, zuclopenthixol

  • action dopaminergic lower neurotransmission of four dopamine pathways (D2 antagonists)
  • therapeutic effect: window is narrow and unique
  • side effects: acute dystonia (EPS) - chronic, akathisia (EPS), pseudo parkinsonism (EPS), tardive dyskinesia (chronic)
  • nurses need to respond quickly to side effects
30
Q

second generation antipsychotics (Atypical)

A
  • second gen: risperidone, olanzapine, quetiapine, ziprasidone, amisulpride, clozapine (final choice)
  • blood monitoring required
  • action block both D2 and 5Ht
  • treat both positive and negative symptoms
  • minimal to no extrapyramidal side effects (EPS) or tardive dyskinesia
  • disadvantage: tendency to cause significant weight gain
  • side effects: sedation, hyperglycemia, akathisia, dizziness, photosensitivity
31
Q

clozapine (second gen antipsychotic)

A
  • first atypical antipsychotic
  • first marketed in 1906, came off market bc of agranulocytosis (low WBC production)
  • reserved for tx: resistant pts
  • requires registration with clozapine monitoring: CSAN#
  • requires base line work up: ECG, blood work
  • CBC weekly for 6 months, then q2w for 6 months, then q4w for duration of treatment
  • give only 7 day supply at first
  • must have at least two trials with other antipsychotics before try clozapine
32
Q

clozapine - side effects

A
  • agranulocytosis
  • myocarditis
  • seizures
  • sialorrea (drooling)
  • weight gain (hyperglycemia-dislipidemia)
  • metabolic syndrome (central obesity, high BP, high triglycerides, low HDL cholesterol, insulin resistance)
33
Q

third generation antipsychotics

A
  • aripiprazole (abilify)
  • dopamine system stabilizer
  • improves positive and negative symptoms and cognitive function
    • little risk of EPS or tardive dyskinesia (EPS of face)
34
Q

newest atypical antipsychotic meds

A
  • iloperidone (fanapt)
  • lurasidone (latuda)
  • asenapine (saphris)
  • paliperidone (invega)
35
Q

potentially dangerous responses to antipsychotics

A
  • agranulocytosis
  • anticholinergic toxicity
  • neuroleptic malignant syndrome (NMS)
36
Q

anticholinergic toxicity (toxidrome)

A
  • blind as a bat: blurred vision
  • mad as a hatter: confused, decreased LOC, seizures, psychosis, delirium, coma
  • red as beet: flushed, vasodilation, tachycardia, dysrhythmias
  • dry as a bone: dry skin, membranes
  • hot as a hare: hyperthermia
  • stuffed as a pipe: urinary/bowel retention
  • myoclonus (quick, involuntary muscle jerks)
37
Q

neuroleptic malignant syndrome (NMS) - FARM

A
  • Fever
  • Autonomic changes (labile, hypertension, tachycardia, tachypnea, diaphoresis, drooling)
  • rigidity of muscles
  • mental status changes (agitation, confusion, delirium, coma)
38
Q

adjunct to antipsychotic drug therapy

A
  • mood stabilizer

- antidepressants

39
Q

interventions

A
  • stabilization and maintenance phases
    • medication admin/adherence
    • community based therapeutic services
    • relationships with trusted care provider
    • counselling and communication techniques (hallucinations, delusions, associative looseness)
    • health teaching and health promotion
40
Q

advanced practice interventions

A
  • individual and group therapy
  • psycho-education
  • med and med monitoring
  • basic health assessment
  • cognitive remediation
  • family therapy
41
Q

interventions: maintenance phase

A
  • teaching for client
  • teaching for family
  • focus on relapse
    • relapse fuel deterioration
    • cause of relapse
    • managing relapse
42
Q

interventions: health promotion phase

A
  • psychiatric rehab and recovery
    • promoting adherence to the medical regimen
    • promoting ADL
    • promoting organized behaviour and insight into illness
    • promoting social interaction and social skills
    • promoting family understanding
43
Q

general health of people with schizophrenia

A
  • 2-4x higher rate of diabetes
  • 8x higher rate of HIV
  • 2x higher asthma
    key modifiable risk factors:
  • hypertension
  • overweight/obesity
  • dyslipidemia
  • hyperglycemia
44
Q

psychological consequences of psychosis

A
  • loss of self esteem
  • loss of confidence
  • developmental stagnation
  • addiction
  • depression
  • PTSD